Q6NTY6
Gene name |
egr1-b |
Protein name |
Early growth response protein 1-B |
Names |
EGR-1-B |
Species |
Xenopus laevis (African clawed frog) |
KEGG Pathway |
xla:414518 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q6NTY6
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q6NTY6-F1 | Predicted | AlphaFoldDB |
No variants for Q6NTY6
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q6NTY6 | |||||
No associated diseases with Q6NTY6
5 regional properties for Q6NTY6
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Zinc finger C2H2-type | 284 - 313 | IPR013087-1 |
| domain | Zinc finger C2H2-type | 314 - 341 | IPR013087-2 |
| domain | Zinc finger C2H2-type | 342 - 369 | IPR013087-3 |
| repeat | Early growth response protein 1, C-terminal | 376 - 462 | IPR021839 |
| domain | Early growth response, N-terminal | 78 - 184 | IPR021849 |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
6 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA-binding transcription factor activity | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. |
| double-stranded methylated DNA binding | Binding to double-stranded methylated DNA. Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks. |
| hemi-methylated DNA-binding | Binding to double-stranded hemi-methylated DNA at replication foci (one strand methylated, while the other strand is unmethylated). Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks. |
| promoter-specific chromatin binding | Binding to a section of chromatin that is associated with gene promoter sequences of DNA. |
| sequence-specific DNA binding | Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
| zinc ion binding | Binding to a zinc ion (Zn). |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| circadian regulation of gene expression | Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours. |
| positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| regulation of DNA-templated transcription | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MALAKTDMLV | SPLQISDPFS | SFPHSPTMDN | YPKLDGAEQF | DHHAADAFSE | MSLSNEKAVL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ESSYANHTTR | LPSLTYTGRF | SLEPAPNSSN | TLWPEPLFSL | VSGLVGMANV | SSSSAPSSSP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SSSSSSSSSS | SSQSPPLSCS | VQSNESSPIY | SAAPTFPNSS | PEMFPDHSPQ | PFQNASTASI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PYPPPAYPVS | KTTFQVPMIP | DYLFPQQQGD | VSLVSADQKP | FQAMENRTQQ | PSLTPLSTIK |
| 250 | 260 | 270 | 280 | 290 | 300 |
| AFATQTSQDL | KTINSTYQSQ | IIKPSRMRKY | PNRPSKTPPH | ERPYACPVES | CDRRFSRSDE |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LTRHIRIHTG | QKPFQCRICM | RNFSRSDHLT | THIRTHTGEK | PFACDICGRK | FARSDERKRH |
| 370 | 380 | 390 | 400 | 410 | 420 |
| TKIHLRQKDK | KADKATPVSI | ASPVSAYSPS | ASTSYPSPVP | TSYSSPVSSC | YPSPVHSSFP |
| 430 | 440 | 450 | 460 | 470 | |
| SPTTAVTYPS | VTSTFQTQCI | TSFPSSIVTN | SYSSPVSSAL | SDMSVTYSPR | TIEIC |